▲ SIGMATERMINAL Open Terminal →

Analyses / NKE

NKE Nike Inc As of Jul 30, 2026
$43.22

Dividend-rich apparel leader grapples with -3.2% revenue decline, 30% China sales drop, and macro softness. Trading 46% below 52-week high.

Setup: Value + Income / Recovery watch Confidence: 62 Horizon: 3-6 months Risk: Medium Category: Large-cap
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals NKE's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

20.4x P/E, 3.8% dividend yield (77% payout), improving insider buy-to-sell ratio (1.27x), modest cash position support dividend. If supply normalization and consumer spending stabilize, upside to mid-to-high 50s plausible. Gross margin (43%) remains healthy despite topline pressure.

▼ Bear Case

Revenue declining YoY (-3.2%), EPS growth -13.4% YoY and -10% over 5Y. China sales fell 30%, a critical market. Price-to-FCF 29x signals cash generation lagging valuation, and weak 8.2% op margin reflects competitive/macro stress. High payout ratio (77%) leaves little buffer if profits erode further.

Valuation

FAIRLY PRICED / SLIGHT DISCOUNT — score 68/100

P/E 20.4x is reasonable for a mature apparel play but elevated given negative growth momentum. P/S 1.37x is in-line with historical range. Price-to-FCF 29x signals cash yield weak vs earnings, raising quality concerns. Dividend yield 3.8% attractive for income, but payout ratio 77% leaves limited margin for earnings setbacks.

Technical Levels

Support · $40.00 (52-week low) · $38.50 (Technical floor (2024 support)) · $43.00 (Prev close / short-term support)

Resistance · $50.00 (Psychological round; 2-year avg) · $55.00 (Test of declining 200-day MA) · $65.00 (Pre-China-crisis level (2023)) · $80.17 (52-week high)

Financial Health

Score 72/100. Liquidity strong (current 1.96, quick 1.19). Balance sheet appears sound with adequate working capital. Debt metrics unavailable but large-cap status & dividend history suggest manageable leverage. No acute solvency risk; longer-term earnings pressure is the concern.

Catalysts

Q3 2024 Earnings (late Oct/early Nov)~6-8 weeksHIGH — will show whether China decline moderating, inventory normalizing, margins recovering. Beat/miss & guidance will drive multi-month directional move.
China consumer spending data & policy stimulusOngoingHIGH — 30% sales drop YoY is biggest headwind. Any stabilization signal critical to stock re-rating.
Consumer spending & holiday retail dataQ4 2024MEDIUM — shapes FY2025 guidance; sets tone for 2024 reacceleration narrative.
Dividend announcement / payout ratio reviewNext earnings or investor dayMEDIUM — high payout ratio (77%) means dividend cut is a risk if earnings weaken further. Maintenance signals confidence.

Risk Flags

China sales down 30% YoY; geopolitical & consumer demand risk material.
EPS & revenue both contracting; profitability momentum negative.
Price-to-FCF 29x vs P/E 20.4x suggests cash generation weaker than earnings report.
Payout ratio 77%; dividend safety depends on stabilized earnings.
Trading 46% below 52-week high; no catalysts visible to trigger mean reversion.
Apparel sector under pressure (see Adidas, VF Corp recent declines).

See NKE's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock NKE free →

Recent News

More Analyses

NKE FAQ

Is NKE a buy right now?

Nike Inc's current read is a Value + Income / Recovery watch setup with 62 confidence over a 3-6 months horizon. Valuation: FAIRLY PRICED / SLIGHT DISCOUNT. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is NKE overvalued?

FAIRLY PRICED / SLIGHT DISCOUNT (valuation score 68/100). P/E 20.4x is reasonable for a mature apparel play but elevated given negative growth momentum. P/S 1.37x is in-line with historical range. Price-to-FCF 29x signals cash yield weak vs earnings, raising quality concerns. Dividend yield 3.8% attractive for income, but payout ratio 77% leaves limited margin for earnings setbacks.

What are the risks of buying NKE?

Revenue declining YoY (-3.2%), EPS growth -13.4% YoY and -10% over 5Y. China sales fell 30%, a critical market. Price-to-FCF 29x signals cash generation lagging valuation, and weak 8.2% op margin reflects competitive/macro stress. High payout ratio (77%) leaves little buffer if profits erode further.